Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.

Bioorg Med Chem

Laboratoire de Chimie Thérapeutique (EA 1043), Faculté des Sciences Pharmaceutiques et Biologiques, Université de Lille, 3, rue du professeur Laguesse, 2, BP 83, 59006 Lille Cedex, France.

Published: May 2008

Benzofuranic analogues of MCA-NAT (5-methoxycarbonylamino-N-acetyltryptamine) have been synthesized and evaluated as melatonin receptor ligands. Introduction of a methoxycarbonylamino substituent in the C-5 position of the benzofurane nucleus obtains MT(3) selective ligands. This selectivity can be modulated with suitable variations of the C-5 position and the acyl group on the C-3 side chain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2008.03.036DOI Listing

Publication Analysis

Top Keywords

c-5 position
8
design synthesis
4
synthesis benzofuranic
4
benzofuranic derivatives
4
derivatives ligands
4
ligands melatonin-binding
4
melatonin-binding site
4
site mt3
4
mt3 benzofuranic
4
benzofuranic analogues
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!